scispace - formally typeset
Search or ask a question
Institution

University of Düsseldorf

EducationDüsseldorf, Germany
About: University of Düsseldorf is a education organization based out in Düsseldorf, Germany. It is known for research contribution in the topics: Population & Transplantation. The organization has 25225 authors who have published 49155 publications receiving 1946434 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: Henry Volzke, y Dietrich Alte,1y Carsten Oliver Schmidt, Dorte Radke, Roberto Lorbeer, Nele Friedrich, Nicole Aumann, Katharina Lau, Michael Piontek, Gabriele Born, Christoph Havemann, Till Ittermann, Sabine Schipf, Robin Haring, Sebastian E Baumeister, Henri Wallaschofski, Matthias Nauck, Stephanie Frick, Andreas Arnold.
Abstract: Henry Volzke, y Dietrich Alte,1y Carsten Oliver Schmidt, Dorte Radke, Roberto Lorbeer, Nele Friedrich, Nicole Aumann, Katharina Lau, Michael Piontek, Gabriele Born, Christoph Havemann, Till Ittermann, Sabine Schipf, Robin Haring, Sebastian E Baumeister, Henri Wallaschofski, Matthias Nauck, Stephanie Frick, Andreas Arnold, Michael Junger, Julia Mayerle, Matthias Kraft, Markus M Lerch, Marcus Dorr, Thorsten Reffelmann, Klaus Empen, Stephan B Felix, Anne Obst, Beate Koch, Sven Glaser, Ralf Ewert, Ingo Fietze, Thomas Penzel, Martina Doren, Wolfgang Rathmann, Johannes Haerting, Mario Hannemann, Jurgen Ropcke, Ulf Schminke, Clemens Jurgens, Frank Tost, Rainer Rettig, Jan A Kors, Saskia Ungerer, Katrin Hegenscheid, Jens-Peter Kuhn, Julia Kuhn, Norbert Hosten, Ralf Puls, Jorg Henke, Oliver Gloger, Alexander Teumer, Georg Homuth, Uwe Volker, Christian Schwahn, Birte Holtfreter, Ines Polzer, Thomas Kohlmann, Hans J Grabe, Dieter Rosskopf, Heyo K Kroemer, Thomas Kocher, Reiner Biffar,17,y Ulrich John20y and Wolfgang Hoffmann1y

925 citations

Journal ArticleDOI
TL;DR: The present data provide Level 2b evidence (Oxford Centre for Evidence-based Medicine) that survival depends on complete resection of enhancing tumor in glioblastoma multiforme and treatment bias was demonstrated regarding resection and second-line therapies.
Abstract: Treatment bias was demonstrated regarding resection and second-line therapies. However, bias and imbalances were controllable in the cohorts available from the 5-aminolevulinic acid study so that the present data now provide Level 2b evidence (Oxford Centre for Evidence-based Medicine) that survival depends on complete resection of enhancing tumor in glioblastoma multiforme.

917 citations

Journal ArticleDOI
Gerald B. Appel1, Gabriel Contreras2, Mary Anne Dooley3, Ellen M. Ginzler4, David A. Isenberg5, David Jayne6, Lei Shi Li, Eduardo Mysler, Jorge Sánchez-Guerrero, Neil Solomons, David Wofsy7, Carlos Abud, Sharon G. Adler8, Graciela S. Alarcón9, Elisa N. Albuquerque10, Fernando Almeida, Alejandro Alvarellos, Gerald B. Appel1, Hilario Avila11, Cornelia Blume12, Ioannis Boletis, Alain Bonnardeaux, Alan Braun, Jill P. Buyon13, Ricard Cervera14, Nan Chen15, Shun-Le Chen15, António Gomes Da Costa16, Razeen Davids17, David D'Cruz18, Enrique de Ramón, Atul Deodhar19, Andrea Doria20, Bertrand Dussol, Paul Emery21, Justus Fiechtner, Jürgen Floege, Hilda Fragoso-Loyo, Richard Furie22, Rozina Ghazalli23, Cybele Ghossein23, Gary S. Gilkeson24, EM Ginzler25, Caroline Gordon8, Jennifer M. Grossman8, Jieruo Gu26, Loïc Guillevin, Pierre Yves Hatron27, Gisela Herrera28, Falk Hiepe28, Frédéric Houssiau, Osvaldo Hübscher, Claudia Hura29, Joshua Kaplan30, Gianna Mastroianni Kirsztajn30, Emese Kiss31, Ghazali Ahmad Kutty, Maurice Laville, Maria Lazaro, Oliver Lenz2, Leishi Li32, Liz Lightstone33, Sam Lim34, Michel Malaise35, Susan Manzi35, Juan Carlos Marcos, Olivier Meyer36, Pablo Monge37, Saraladev Naicker37, Nathaniel Neal38, Michael Neuwelt39, Kathy Nicholls40, Nancy J. Olsen40, José Ordi-Ros41, Barbara E. Ostrov42, Manuel Pestana43, Michelle Petri44, G. Pokorny44, Jacques Pourrat15, Jiaqi Qian15, Jai Radhakrishnan1, Brad H. Rovin, Julio Sanchez Roman, Joseph C. Shanahan45, William Shergy, Fotini Skopouli, Alberto Spindler46, Christopher Striebich47, Robert Sundel48, Charles R. Swanepoel48, Yen Tan Si49, Guillermo Tate, Vladimír Tesaŕ37, Mohamed Tikly37, Haiyan Wang, Rosnawati Yahya50, Xueqing Yu26, Fengchun Zhang50, Diana Zoruba 
Columbia University1, University of Miami2, University of North Carolina at Chapel Hill3, SUNY Downstate Medical Center4, University College London5, Cambridge University Hospitals NHS Foundation Trust6, University of California, San Francisco7, University of California, Los Angeles8, University of Alabama at Birmingham9, Rio de Janeiro State University10, University of Guadalajara11, University of Düsseldorf12, New York University13, University of Barcelona14, Shanghai Jiao Tong University15, University of Lisbon16, Stellenbosch University17, Guy's and St Thomas' NHS Foundation Trust18, Oregon Health & Science University19, University of Padua20, University of Leeds21, North Shore-LIJ Health System22, Northwestern University23, Medical University of South Carolina24, University of Birmingham25, Sun Yat-sen University26, Lille University of Science and Technology27, Charité28, Rutgers University29, Federal University of São Paulo30, University of Debrecen31, Imperial College London32, Emory University33, University of Liège34, University of Pittsburgh35, University of Paris36, University of the Witwatersrand37, California State University, Long Beach38, Royal Melbourne Hospital39, University of Texas Southwestern Medical Center40, Autonomous University of Barcelona41, Pennsylvania State University42, Johns Hopkins University43, University of Szeged44, Duke University45, University of Colorado Denver46, Harvard University47, University of Cape Town48, University of Malaya49, Peking Union Medical College50
TL;DR: Although most patients in both treatment groups experienced clinical improvement, the study did not meet its primary objective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.
Abstract: Recent studies have suggested that mycophenolate mofetil (MMF) may offer advantages over intravenous cyclophosphamide (IVC) for the treatment of lupus nephritis, but these therapies have not been compared in an international randomized, controlled trial. Here, we report the comparison of MMF and IVC as induction treatment for active lupus nephritis in a multinational, two-phase (induction and maintenance) study. We randomly assigned 370 patients with classes III through V lupus nephritis to open-label MMF (target dosage 3 g/d) or IVC (0.5 to 1.0 g/m(2) in monthly pulses) in a 24-wk induction study. Both groups received prednisone, tapered from a maximum starting dosage of 60 mg/d. The primary end point was a prespecified decrease in urine protein/creatinine ratio and stabilization or improvement in serum creatinine. Secondary end points included complete renal remission, systemic disease activity and damage, and safety. Overall, we did not detect a significantly different response rate between the two groups: 104 (56.2%) of 185 patients responded to MMF compared with 98 (53.0%) of 185 to IVC. Secondary end points were also similar between treatment groups. There were nine deaths in the MMF group and five in the IVC group. We did not detect significant differences between the MMF and IVC groups with regard to rates of adverse events, serious adverse events, or infections. Although most patients in both treatment groups experienced clinical improvement, the study did not meet its primary objective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.

909 citations

Journal ArticleDOI
TL;DR: It is found that for Au nanowires, Young's modulus is essentially independent of diameter, whereas the yield strength is largest for the smallest diameter wires, with strengths up to 100 times that of bulk materials, and substantially larger than that reported for bulk nanocrystalline metals.
Abstract: Nanowires have attracted considerable interest as nanoscale interconnects and as the active components of both electronic and electromechanical devices. Nanomechanical measurements are a challenge, but remain key to the development and processing of novel nanowire-based devices. Here, we report a general method to measure the spectrum of nanowire mechanical properties based on nanowire bending under the lateral load from an atomic force microscope tip. We find that for Au nanowires, Young's modulus is essentially independent of diameter, whereas the yield strength is largest for the smallest diameter wires, with strengths up to 100 times that of bulk materials, and substantially larger than that reported for bulk nanocrystalline metals (BNMs)1,2,3,4,5. In contrast to BNMs, nanowire plasticity is characterized by strain-hardening, demonstrating that dislocation motion and pile-up is still operative down to diameters of 40 nm. Possible origins for the different mechanical properties of nanowires and BNMs are discussed.

900 citations

Journal ArticleDOI
TL;DR: Mitoxantrone 12 mg/m(2) was generally well tolerated and reduced progression of disability and clinical exacerbations and the frequency of long-term drug-related side-effects.

894 citations


Authors

Showing all 25575 results

NameH-indexPapersCitations
Karl J. Friston2171267217169
Roderick T. Bronson169679107702
Stanley B. Prusiner16874597528
Ralph A. DeFronzo160759132993
Monique M.B. Breteler15954693762
Thomas Meitinger155716108491
Karl Zilles13869272733
Ruben C. Gur13674161312
Alexis Brice13587083466
Michael Schmitt1342007114667
Michael Weller134110591874
Helmut Sies13367078319
Peter T. Fox13162283369
Yuri S. Kivshar126184579415
Markus M. Nöthen12594383156
Network Information
Related Institutions (5)
Ludwig Maximilian University of Munich
161.5K papers, 5.7M citations

97% related

Heidelberg University
119.1K papers, 4.6M citations

96% related

University of Zurich
124K papers, 5.3M citations

95% related

University of Pittsburgh
201K papers, 9.6M citations

94% related

National Institutes of Health
297.8K papers, 21.3M citations

94% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023139
2022470
20213,130
20202,720
20192,507
20182,439